Hitachi to buy Mitsubishi Electric's particle therapy business
08-Dec-17, Nikkei Asian Review
Hitachi will acquire Mitsubishi Electric's particle therapy equipment business as it seeks to tap growing demand abroad for advanced cancer treatment systems.
%20Nikkei%20Asian%20Reveiw.jpg "Hitachi to buy Mitsubishi Electric's particle therapy business (c) Nikkei Asian Reveiw")
Image: Nikkei Asian Review
%20Nikkei%20Asian%20Reveiw.jpg "Hitachi to buy Mitsubishi Electric's particle therapy business (c) Nikkei Asian Reveiw")
The business, which encompasses development, production, sales and maintenance, will be transferred to Hitachi to form a new organization in Apr-18.
Mitsubishi Electric controls slightly more than 50% of the domestic market for particle therapy systems, while Hitachi holds a nearly 20% share. With domestic demand mostly filled, the industry likely faces gradual declines.